Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X


Lixisenatide is currently undergoing phase III GetGoal clinical trial programme, which is expected to be completed in the second quarter of 2011.

Go Top